Search for: "BAYER MANUFACTURING" Results 641 - 660 of 980
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Apr 2011, 3:01 pm by Oliver G. Randl
Pigment Yellow 150” for the manufacture of LCD colour filters […].[3.2] The annexes to document D8 provide evidence for the following facts: A fax from Bayer AG to Bayer Ltd. in Tokyo, sent on March 15, 1999, refers to the delivery of 600 kg of “BABYPLAST Yellow 5GN1 01” of batch FA 320 016. [read post]
5 Apr 2011, 10:39 pm
The manufacturer has stopped running any advertisements that claim the pills can help with symptoms of PMS and clearing up acne. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
26 Mar 2011, 8:13 pm
If you or someone that you love developed the following health conditions after taking any of these pills, you may have grounds for a Massachusetts products liability case against the drug manufacturer. [read post]
25 Mar 2011, 7:48 am by Stefanie Levine
Patent No. 6,232,328 entitled NON-SYSTEMIC CONTROL OF PARASITES and owned by Bayer Animal Health GmbH. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany: Düsseldorf… [read post]
7 Mar 2011, 7:44 am by Kali Borkoski
Bayer — another in the series of challenges to reverse payments by brand name manufacturers to generic manufacturers. [read post]
6 Mar 2011, 9:11 pm
The FDA accused the company of false advertising, and of unsanitary conditions in one of its manufacturing plants. [read post]
28 Feb 2011, 8:27 am by Antitrust Today
Bayer AG (In re Ciprofloxacin Hydrochloride Antitrust Litig.), 05-2851-cv(L) (2d Cir. 2010) (“Cipro”). [read post]
3 Feb 2011, 2:11 pm by Bexis
Aug. 30, 2007) (FDA compliance precludes conduct being outrageous).More generally, IIED claims have been dismissed against drug/device manufacturers because IIED is seen as a tort involving personal affront. [read post]
26 Jan 2011, 3:01 pm
 The Kat now sees that licensing has already been thought of in the context of pay-to-delay, is is apparent from the application for certiorari in Louisiana Wholesale v Bayer (here). [read post]
20 Jan 2011, 10:09 pm
Many drug injury lawsuits are being filed against drug manufacturing giants such as Bayer, Johnson & Johnson, Wyeth and GlaxoSmithKline. [read post]
19 Jan 2011, 8:47 am by Michael Carrier
  Brand-name drug manufacturers pay generic firms to settle patent litigation and delay entering the market. [read post]
11 Jan 2011, 11:07 pm by Kelly
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
10 Jan 2011, 11:49 am by Dennis Crouch
This situation most often emerges in the pharmaceutical market between innovator companies and generic manufacturers. [read post]